APA (7th ed.) Citation

L, L., W, X., Z, S., T, W., X, L., Y, G., . . . X, G. (2022). Addition of 3-methoxytyramine or chromogranin A to plasma free metanephrines as the initial test for pheochromocytoma and paraganglioma: Which is the best diagnostic strategy. Clinical endocrinology, 96(2), 132. https://doi.org/10.1111/cen.14585

Chicago Style (17th ed.) Citation

L, Liu, Xie W, Song Z, Wang T, Li X, Gao Y, Li Y, Zhang J, and Guo X. "Addition of 3-methoxytyramine or Chromogranin A to Plasma Free Metanephrines as the Initial Test for Pheochromocytoma and Paraganglioma: Which Is the Best Diagnostic Strategy." Clinical Endocrinology 96, no. 2 (2022): 132. https://doi.org/10.1111/cen.14585.

MLA (9th ed.) Citation

L, Liu, et al. "Addition of 3-methoxytyramine or Chromogranin A to Plasma Free Metanephrines as the Initial Test for Pheochromocytoma and Paraganglioma: Which Is the Best Diagnostic Strategy." Clinical Endocrinology, vol. 96, no. 2, 2022, p. 132, https://doi.org/10.1111/cen.14585.